These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7524457)

  • 21. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass.
    Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1994 Oct; 58(4):1036-9. PubMed ID: 7524460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical application of aprotinin in cardiac surgery.
    Isgro F; Stanisch O; Kiessling AH; Gürler S; Hellstern P; Saggau W
    Perfusion; 2002 Sep; 17(5):347-51. PubMed ID: 12243438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
    Mohr R; Goor DA; Lusky A; Lavee J
    Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit.
    Ray MJ; Hales MM; Brown L; O'Brien MF; Stafford EG
    Ann Thorac Surg; 2001 Aug; 72(2):521-6. PubMed ID: 11515892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass.
    Harder MP; Eijsman L; Roozendaal KJ; van Oeveren W; Wildevuur CR
    Ann Thorac Surg; 1991 Jun; 51(6):936-41. PubMed ID: 1710098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of aprotinin on plasma levels of neutrophil elastase and postoperative blood loss in cardiac surgery.
    Dernek S; Sevin B; Aslan R; Kaklikkaya I; Atalay C; Kural T
    Cardiovasc Surg; 1996 Aug; 4(4):515-9. PubMed ID: 8866093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative use of aprotinin in cardiac operations: an alternative to its prophylactic use.
    Ciçek S; Demirkiliç U; Ozal E; Kuralay E; Bingol H; Tatar H; Ozturk OY
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1462-7. PubMed ID: 8975837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aprotinin vs. tranexamic acid in isolated coronary artery bypass surgery: A multicentre observational study.
    Deloge E; Amour J; Provenchère S; Rozec B; Scherrer B; Ouattara A
    Eur J Anaesthesiol; 2017 May; 34(5):280-287. PubMed ID: 28221207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of high-dose aprotinin during nonprimary cardiovascular surgery: case reports and review of the literature.
    Whitten CW; Allison PM; Morse LM; Latson TW
    J Clin Anesth; 1994; 6(6):515-20. PubMed ID: 7533505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
    Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
    Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
    Alderman EL; Levy JH; Rich JB; Nili M; Vidne B; Schaff H; Uretzky G; Pettersson G; Thiis JJ; Hantler CB; Chaitman B; Nadel A
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):716-30. PubMed ID: 9806378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass.
    Gurian DB; Meneghini A; Abreu LC; Murad N; Matos LL; Pires AC; Valenti VE; Breda JR
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):615-20. PubMed ID: 23434921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypass.
    Liu B; Belboul A; Rådberg G; Tengborn L; Dernevik L; Roberts D; William-Olsson G
    Scand J Thorac Cardiovasc Surg; 1993; 27(3-4):149-55. PubMed ID: 7515193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
    Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
    J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin.
    Schönberger JP; Bredée JJ; van Oeveren W; van Zundert AA; Verkroost M; Terwoorst J; Bavinck JH; Berreklouw E; Wildevuur CR
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):262-7. PubMed ID: 7688059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
    Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.